The USA Chronic Venous Insufficiency Interventional landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook (2021-2026)
The USA Chronic Venous Insufficiency report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with performing physicians in Interventional Radiology and Vascular Surgery departments from academic/university hospitals, community teaching hospitals, non-teaching hospitals, and private practice in the USA.
The report covers:
Chronic venous insufficiency procedures
Interventional devices: used in RF ablation, laser ablation, endovenous cyanoacrylate ablation, mechanochemical endovenous ablation, and endothermal heat-induced thrombosis
Procedure trends: stages of the disease, chronic venous insufficiency types, performing departments, route of access used for the intervention, and type of interventions
Insights on hospital structure and utilization, physician treatment selection criteria, current and upcoming policies for diagnosis and treatment, and payer coverage are delved into.
Physicians’ brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others effecting brand usage have been covered.stages of the disease, chronic venous insufficiency types, performing departments, route of access used for the intervention, and type of interventions
Future trends such as the introduction of novel radiofrequency ablation catheters for treating incompetent perforators are covered. The report highlights disruptive technology for increasing microcirculatory blood flow and for stimulation of the calf muscles to prevent venous thrombosis in surgical and non-surgical patients. The report also captures the increasing demand for minimally invasive treatments for treating chronic venous insufficiency.
Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as the acquisition of Venclose Inc. by Becton Dickinson are covered in the report
What’s in it for you?
This report will help chronic venous insufficiency treatment device companies understand the chronic venous insufficiency treatment devices landscape, procedural and technology trends, the brand perception, in the USA.
The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the chronic venous insufficiency treatment devices market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model. REPORT COST: 5,000 USD
Contact us below for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.